Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Arthritis, Rheumatoid 8Melanoma 6Colitis, Ulcerative 6Inflammatory Bowel Diseases 5Crohn Disease 5Carcinoma, Non-Small-Cell Lung 4Lung Neoplasms 3Colitis 3Urogenital Neoplasms 2Inflammation 2Hematologic Neoplasms 2Graft vs Host Disease 2Fatigue 2Depressive Disorder, Major 2Depression 2Cachexia 2Anorexia 2Vasculitis 1Takayasu Arteritis 1Syndrome 1Stroke 1Stevens-Johnson Syndrome 1Spondylitis, Ankylosing 1Skin Neoplasms 1Recurrence 1Rare Diseases 1Psoriasis 1Precancerous Conditions 1Pemphigoid, Benign Mucous Membrane 1Pancreatic Neoplasms 1

Interventions

Therapeutics 31Psychiatric Rehabilitation 27Surveys and Questionnaires 15Cognitive Behavioral Therapy 12Early Intervention, Educational 10Psilocybin 9Ketamine 9Methods 8Saline Solution 7Yoga 6Mindfulness-Based Cognitive Therapy 6Interviews as Topic 6Esketamine 6Counseling 6Psychosocial Intervention 5Mindfulness 5Methylphenidate 5Escitalopram 5Educational Status 5Behavior Therapy 5Acupuncture Therapy 5Palliative Care 4Exercise Therapy 4Exercise 4Control Groups 4Caregivers 4Standard of Care 3Psychotherapy 3Niacin 3Mindfulness-Based Stress Reduction 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Depression × Infliximab × Clear all
NCT00463580 2025-07-08

Infliximab

Emory University

Phase 4 Completed
60 enrolled 15 charts

Bipolar Disorder, Depression, Depressive Disorder, Major, Depressive Disorder, Treatment-Resistant

NCT06136546 2025-05-07

Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab

Massachusetts General Hospital

Phase 2 Recruiting
100 enrolled

Depression, Depressive Disorder, Major, Inflammation, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡